Dosage compensation in mammals occurs at two levels. In addition to balancing X-chromosome dosage between males and females via X inactivation, mammals also balance dosage of Xs and autosomes. It has been proposed that X-autosome equalization occurs by upregulation of Xa (active X). To investigate mechanism, we perform allele-specific ChIP-seq for chromatin epitopes and analyze RNA-seq data. The hypertranscribed Xa demonstrates enrichment of active chromatin marks relative to autosomes. We derive predictive models for relationships among Pol II occupancy, active mark densities and gene expression, and we suggest that Xa upregulation involves increased transcription initiation and elongation. Enrichment of active marks on Xa does not scale proportionally with transcription output, a disparity explained by nonlinear quantitative dependencies among active histone marks, Pol II occupancy and transcription. Notably, the trend of nonlinear upregulation also occurs on autosomes. Thus, Xa upregulation involves combined increases of active histone marks and Pol II occupancy, without invoking X-specific dependencies between chromatin states and transcription.
a r t i c l e s In many organisms, sex is determined genetically by dimorphic sex chromosomes. In the XY-based system, females are homogametic (XX) and males are heterogametic (XY) 1, 2 . Current evolutionary theories suggest that sex chromosomes evolved from a pair of autosomal homologs, and acquisition of favorable male genes on the Y led to a suppression of recombination, making gradual loss of Y-chromosome material inevitable. Degeneration of the Y would have resulted in a continual series of sudden changes in gene dosage balance not only between male and female Xs but also between X chromosomes and autosomes 1 . Ohno predicted that two types of dosage compensation schemes must therefore exist [2] [3] [4] . For mammals, the existence of X-chromosome inactivation (XCI) to silence one of the two X chromosomes in females has been known since 1961 (ref. 5, 6) . This mechanism equalizes X-chromosome dosage between the sexes and depends on expression of Xist RNA [7] [8] [9] coupled with recruitment of PRC2 complex [10] [11] [12] . But because XCI creates another level of dosage imbalance, this one between Xs and autosomes of both sexes, a secondary compensatory mechanism must target the active X chromosome (Xa) and double its transcription to restore genome-wide balance.
Several recent studies support the idea of X hyperactivation in mammals. Microarray-based gene expression profiling of mammalian tissues showed that in both sexes X-linked genes are expressed not at half the average autosomal dose (as would be expected if expression came from a single X) but at nearly the same dose as autosomal genes, implying that Xa is upregulated in both males and females 13, 14 . These conclusions have been challenged by analysis of RNA-Seq data, which showed that the expression average of X-linked genes was approximately half that of the autosomal average 15 . A more recent study, however, indicates that this interpretation was confounded by the inclusion of silent genes on the X chromosome 16 .
Here we take an alternate approach to address whether and how dosage compensation occurs between X and autosomes by investigating chromatin signatures on a genome-wide scale. We carry out allele-specific chromatin immunoprecipitation with deep sequencing (ChIP-seq) for RNA polymerase II (Pol II) and active chromatin marks and, through a combined analysis with RNAseq data, we find that Xa upregulation indeed occurs. The data suggest that Xa upregulation occurs at the level of both transcription initiation and elongation and point to nonlinear quantitative dependencies among active histone marks, Pol II occupancies and transcription output that are not X chromosome specific and are part of a genome-wide mechanism for quantitative control of gene expression.
RESULTS

Confirmation of Xa upregulation
To address how X-linked transcription compares to autosomal transcription in the female soma and whether the differences, if any, could be explained by chromatin mechanisms, we first compared average gene expression of all X-linked and autosomal genes using previously published RNA-seq data from a mouse female embryonic kidney fibroblast cell line 17 . We calculated gene expression levels as fragments per kilobase per million (FPKM) values for nonoverlapping RefSeq mouse genes using the TopHat and Cufflinks methods, and found that the total FPKM averages of haploid X and a r t i c l e s autosomal genes differed only by 22%. This conclusion is consistent with the argument that Xa hyperactivation does not occur 15 .
However, the X chromosome may harbor more silent genes than do autosomes. Reasoning that this difference could confound measurements of average transcriptional output, we categorized genes with respect to their expression status (active versus inactive) and CpG content (high versus low) at the promoters (Supplementary Fig. 1a) . A natural FPKM cutoff of ~1.0 for actively expressed genes was suggested by the analyses of dependency between gene expression and Pol II densities across the gene body ( Supplementary Fig. 2 ; see Online Methods). We observed that almost 57% of X-linked genes showed low CpG content at promoters (LCP), most of which show very little to no transcription (representing an inactive state). When analysis of the RNA-seq data was performed using only expressed genes, the X chromosome showed 85% higher mean expression than the average haploid autosome set, with 57% difference in median values ( Supplementary Table 1 ). X hypertranscription was apparent among both active HCP and active LCP genes ( Supplementary  Fig. 1b ). Differences between autosomal and X-linked gene populations were highly significant (Supplementary Table 1 , Mann-Whitney P values; Supplementary Fig. 1c ). Thus, in agreement with previous reports 13, 14, 16 , the mammalian X is dosage compensated with respect to autosomes.
Enrichment of active histone marks and Pol II on Xa
Next, we asked whether X:A dosage compensation has a chromatin basis. Over the years, genome-wide profiles of histone marks have been generated by array-based chromatin immunoprecipitation (ChIP-on-chip) or ChIP-seq. In every case, the analysis was performed either in male cell lines 18, 19 or in female lines without the allele specificity and sequencing depth necessary to distinguish Xa from inactive X (Xi) with sufficient resolution [20] [21] [22] . Here we performed high-resolution, allele-specific ChIP-seq in a clonal F 1 hybrid female mouse fibroblast line that carries one haploid chromosome set of Mus musculus (mus) origin and a second haploid set of Mus castaneus (cast) origins. We examined active chromatin signatures that are associated with the transcription start site (TSS), including Pol II phosphorylation at Ser5 (Pol II-S5P) and histone H3 trimethylation at Lys4 (H3K4me3), both of which are associated with transcription initiation; we also examined signatures associated with transcription elongation through the gene body, including phosphorylation of Pol II at Ser2 (Pol II-S2P) and H3 trimethylation at Lys36 (H3K36me3) 23, 24 . By using paired-end sequencing, we could uniquely align 83-93% of the 17-28 million read pairs to the genome, yielding 16.5-21.9 million uniquely aligned reads per epitope ( Supplementary Table 2 ).
With ~22 million SNP and ~1 million insertion or deletion (indels) differences between mus and cast genomes 25 , ~35% of all paired reads could be assigned to specific alleles (S.F.P., R.I.S., E.Y. and J.T.L., data not shown). Analysis of monoallelically expressed loci, including the Zim1-Peg3 imprinted domain ( Fig. 1a and data not shown), confirmed the allele-specific output of the ChIP-seq. As expected, active marks were found on the paternally expressed Peg3 allele (cast) and the maternally expressed Zim1 allele (mus). Elsewhere in the genome, active marks were evenly distributed between autosomal homologs, as expected ( Fig. 1b) . By contrast, on the X-chromosome, active marks were predominantly on X cast (Xa), consistent with the occurrence of XCI.
To determine whether Xa hypertranscription is reflected in enrichment of active chromatin marks, we compared coverages on X cast (Xa) with those on autosomes of M. castaneus origin. When we calculated medians for coverage densities on active genes, Xa showed 31% more Pol II-S5P and 24% more H3K4me3 coverage around the TSS; Xa also showed 20% more Pol II-S2P and 9% H3K36me3 coverage on the gene bodies ( Fig. 2; Supplementary Table 1 ). The enrichments were statistically significant in each category ( Supplementary Table 1 ), except for Pol II-S2P and H3K36me3 on LCP active genes, presumably because of the smaller sample of LCP active genes on Xa (n = 72). Moreover, distributions of density values for all marks followed a similar shape ( Fig. 2) , suggesting that enrichment of Xa marks was global and could not be attributed to a distinct subset with exceptionally high coverage. a r t i c l e s
Nonlinear dependencies between active marks and transcription
Notably, the enrichment of Pol II and active histone marks on Xa relative to autosomes was not proportional to the nearly two-fold transcriptional upregulation on Xa ( Fig. 2 and Supplementary Table 1 ). Indeed, the degree of epitope enrichment was much less than two-fold.
To explain this disparity, we compared Pol II and histone mark densities against transcription output genome wide. Plotting Pol II-S2P against FPKM (transcription) values revealed a good correlation between gene expression and the elongating form of Pol II, as expected. It also demonstrated a natural separation of active genes from inactive ones ( Supplementary Fig. 2 : dotted horizontal line, FPKM cutoff of ~1.0) regardless of gene category (HCP, LCP, all genes). Therefore, in subsequent analyses, we used active genes of all three categories to investigate the relationship between chromatin epitope and transcription output. The relationship between transcription output and chromatin epitopes is shown by scatter plots and point densities for Xa (black line contours) and autosomal (color contours) genes in pairwise comparisons between expression and various chromatin epitopes ( Fig. 3 and Supplementary Figs. 3 and 4) . For active HCP M. castaneus alleles, we found pronounced dependencies between gene expression and Pol II-S5P, Pol II-S2P and active histone marks, regardless of whether they were X-linked or autosomal ( Fig. 3a-d) . Similar strong dependencies were observed between Pol II-S5P and H3K4me3 densities, and between Pol II-S2P and H3K36me3 densities ( Fig. 3e-h) .
Similar trends were also found in the populations of all active (HCP+LCP) and active LCP genes (Supplementary Figs. 3 and 4) . These data showed that Xa and autosomal genes are subject to similar quantitative relationships between active chromatin marks and Pol II and transcription output.
These dependencies have several universal features that might provide general insight into the mechanism of Xa upregulation. First, the relationships showed monotonic trends: increases in Pol II or active histone marks densities were accompanied by corresponding average increases in gene expression. Second, the relationship was nonlinear, as an increase in the input variable (for example, Pol II-S5P or H3K4me3) resulted in a much higher increase in the readout (for example, expression). The relationship could be linearized by using log-log scale transformation, which suggested a power-law relationship. This type of dependency is consistent with previously published analysis of correlations between expression a r t i c l e s and histone mark densities at promoters 26 . The only exceptions were H3K36me3 comparisons against all other epitopes. For both Xa and autosomal genes, a log scale transformation better linearized the trend for the gene body H3K36me3 (Fig. 3f,h and Supplementary Figs. 3  and 4) , implying that relatively smaller changes in H3K36me3 can produce large changes in transcription output. The overall nonlinearity suggests potential collective effects in the regulation of transcriptional activity via changes in chromatin state and Pol II occupancy. Notably, the nonlinear nature of these dependencies allows for signal amplification: for example, a 20-30% increase in Pol II density corresponds to a larger increase in gene expression ( Fig. 3a,b) .
Third, although Xa and autosomal genes obeyed a common trend of dependency between gene expression and active chromatin and Pol II marks, the Xa scatter plot demonstrated consistent shifts along the autosomal trend line to higher positions on both x and y axes ( Fig. 3 and Supplementary Figs. 3 and 4) , reflecting the generally higher levels of gene expression, Pol II occupancy, and H3K4me3 and H3K36me3 deposition on Xa relative to autosomes. In comparison to autosomes, Xa genes generally showed better correlations between chromatin epitopes (Fig. 4a) , possibly reflecting the generally greater Xa values. Although ranges for these variables on Xa overlapped with those of autosomes, there was a clear distinction between the two gene populations, consistent with the significant (P values <0.001) differences in the means and medians of epitope density coverages (Supplementary Table 1, Supplementary  Fig. 1c and Fig. 1b) .
Taken together, these data enable us to draw several conclusions regarding Xa upregulation. The similar nonlinear trends of relationships for Xa and autosomal genes suggest that Xa upregulation might be explained by chromatin-based mechanisms that are generally used throughout the genome. On both Xa and autosomes, nonlinearity of the dependencies provide a mechanism for signal amplification (Fig. 4b) .
For example, Xa upregulation might be explained simply by increased density of active epigenetic marks associated with increased Pol II occupancy, rather than by Xa-specific rules governing the relationship between histone marks, Pol II and transcription. Our data also indicate that-unlike in fruit flies, where enhanced transcription elongation has been proposed to be the primary mode of Xa upregulation 27 -the mammalian mechanism shows a strong influence of enhanced transcription initiation, as both Pol II-S5P and H3K4me3 have ~30% increased coverage at the TSS of active Xa genes. At the same time, however, mammalian Xa upregulation is also associated with an ~20% increase in Pol II-S2P and ~9% increase in H3K36me3 coverages across gene bodies, implying that elongation is also facilitated on Xa. We therefore propose that Xa upregulation involves both enhanced transcription initiation and enhanced elongation that depend on increased trimethylation of H3K4 and H3K36, which amplify gene expression in a nonlinear fashion (Fig. 4b) .
Principles of activation are shared between Xa and autosomes
We tested this hypothesis by deriving models of gene expression based on autosomal active mark occupancy and applying these models to Xa. The resulting predictions of X-linked gene expression showed accordance with the observed values (Pearson's r = 0.71) ( Fig. 4c) . Moreover, autosomal models based on any combination of marks, when applied to an individual autosome, produced a correlation between predicted and observed values similar to that of Xa ( Supplementary Table 3 ; see Online Methods for details). These results indicated that, first, quantitative relationships between active histone mark densities, Pol II occupancy and gene expression had predictive power, consistent with the results of others 26 . Second, trends observed in autosomes were remarkably predictive of X-linked gene expression. Together, these conclusions argue that Xa upregulation is governed by principles that are not unique to X but are applicable throughout the genome.
DISCUSSION
We have tested the hypothesis of Xa upregulation using a new, unbiased approach and asked whether this arm of dosage compensation is based on chromatin mechanisms similar to those observed on autosomes. Through allele-specific ChIP-seq and RNA-seq analysis, we conclude that dosage compensation of Xa does occur, in agreement with previously published studies 13, 14, 16 . The inability of a separate study 15 to detect Xa upregulation stems from the inclusion of inactive genes. When we considered all genes regardless of expression status, the average difference was masked by the unusually high fraction of silent genes (genes with low CpG content) on the X chromosome. Earlier studies 13, 14 also included both active and inactive genes; however, microarrays have a lower dynamic range, and it is likely that the analysis heavily favored highly transcribed genes. a r t i c l e s
We then focused on potential mechanisms of Xa upregulation. By analyzing the genome-wide allelic distribution of Pol II and active chromatin marks in the context of gene expression 17 , we found that Xa was enriched for Pol II-S5P, Pol II-S2P, H3K4me3 and H3K36me3 relative to the haploid autosome set. Scatter plots ( Fig. 3 and Supplementary Figs. 3 and 4) showed a clear rightward and upward shift of Xa contours relative to autosomal contours, along the autosomal trend line to the higher levels of active marks and expression. However, the degree of Pol II enrichment on Xa and the coverage of active histone marks did not scale proportionally with increased transcription output from Xa. This nonlinearity enables signal amplification with small changes in chromatin structure and Pol II density. An unexpected observation was that the nonlinear dependencies applied to autosomes and X alike, as suggested by all pairwise plots ( Fig. 3 and Supplementary  Figs. 3 and 4) and by the quality of predicting Xa genes based on the autosome-based models ( Fig. 4c and Supplementary Table 3) . The similar quantitative relationships suggest that chromatinbased processes governing Xa upregulation are used genome wide and that dosage compensation of Xa and autosomes do not require X-specific principles to bring about the ~2-fold upregulation. Importantly, while the nonlinear power laws apply to both Xa and autosomes, we do not exclude the possibility that Xa-specific factors are required to initiate the chromatin-based enhancement. Such factors could target Xa to a special compartment or lead to association with nuclear pore factors, as has been suggested for Drosophila melanogaster 28 .
Our data imply the existence of both similarities and differences between Xa upregulation in mammals and in the fruit fly. In D. melanogaster, the X-chromosome dosage between XX and XY individuals is equalized by hypertranscription of the single male X chromosome [29] [30] [31] . With this mechanism, the fly compensates for differences between X and autosomal gene dosage at the same time that it achieves male-to-female X-chromosome balance. This process requires cooperation between MOF histone acetyltransferase 32 , MSL complexes [33] [34] [35] and the long noncoding RNA, roX1 and roX2 (refs. 36,37) . Together, they bring about precise chromatin change leading to ~2-fold upregulation of the male X chromosome 27, 30, [38] [39] [40] [41] [42] [43] [44] [45] . An alternative mechanism proposes less dependency on MSL-driven hyperactivation and more on the genome's inherent ability to correct for dosage imbalances-via the so-called "inverse effect" 32, 46 . This mechanism may also operate in mammalian Xa upregulation.
X hyperactivation in the fruit fly has been proposed to be achieved primarily through enhanced transcription elongation 27, 38, [43] [44] [45] . In our system, differences in distributions of Pol II-S5P, Pol II-S2P, H3K4me3 and H3K6me3 argue that Xa upregulation is controlled through transcription initiation, but enhancement of elongation is also a strong possibility. Whereas Pol II-S5P and H3K4me3 coverages increase ~30% at the TSS of Xa genes, Pol II-S2P and H3K36me3 coverages also increase ~20% and ~9%, respectively, across gene bodies. In conclusion, we favor a model in which Xa upregulation is effected by both enhanced transcription initiation and elongation via nonlinear dynamics. Future studies will focus on whether and how Xa-specific factors might be involved in initiating hypertranscription through the chromatin-based mechanisms identified herein.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Accession codes. GEO: GSE33823.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
